Superior preclinical efficacy of co-treatment with BRG1/BRM and FLT3 inhibitor against AML cells with FLT3 mutations
BRG1/BRM与FLT3抑制剂联合治疗对FLT3突变型AML细胞具有优异的临床前疗效
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01251-7
Fiskus, Warren; Mill, Christopher P; Piel, Jessica; Collins, Mike; Hentemann, Murphy; Cuglievan, Branko; Birdwell, Christine E; Das, Kaberi; Hou, Hanxi; Davis, John A; Jain, Antrix; Malovannaya, Anna; Kadia, Tapan M; Daver, Naval; Sasaki, Koji; Takahashi, Koichi; Hammond, Danielle; Reville, Patrick K; Flores, Lauren B; Loghavi, Sanam; Su, Xiaoping; DiNardo, Courtney D; Bhalla, Kapil N